neurological autoimmune diseases Archives - Buhlmann Diagnostics Corp

Tag: neurological autoimmune diseases

Visit BUHLMANN @ AMLI 2024 (LIVE)

AMLI 2024 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Visit www.buhlmannlabs.com or email info@buhlmannlabs.com for more information.   AMLI 2024 37th AMLI Annual Meeting Aug 16-19,
Continue Reading

Visit BUHLMANN @ AMLI 2023 (LIVE)

AMLI 2023 Assay Offering: BUHLMANN is proud to partner with this event. We offer a comprehensive Immunology assay product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications. Visit www.buhlmannlabs.com or email info@buhlmannlabs.com for more information.   AMLI 2023 36th AMLI Annual Meeting Aug 11-14,
Continue Reading

Check Us Out at AMLI 2019

We offer a comprehensive autoimmunity product line comprised of robust assays for simple, esoteric testing for important markers and it is supported by numerous publications.  Anti-MAG Autoantibodies ELISA  US: Research Use Only.  Not for use in diagnostic procedures. Canada: Health Canada License: 89118 This assay is intended for the quantitative determination of human IgM-auto-antibodies directed
Continue Reading

Diagnostics of anti-MAG antibody polyneuropathy

Anti-MAG Autoantibodies ELISA: Franciotta,D., Gastaldi, M., et al. Diagnostics of anti-MAG antibody polyneuropathy.  Neurological Sciences; (2017) 38(Suppl 2): 249. PMID: 29030772 DOI: 10.1007/s10072-017-3024-4 Highlights from this Publication “This document presents the guidelines for anti-myelin-associated glycoprotein (MAG) antibody testing that have been developed following a consensus process built on questionnaire-based surveys, internet contacts, and discussions at workshops of sponsoring Italian Association of
Continue Reading